{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T09:26:27Z","timestamp":1787563587522,"version":"build-2736575974"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T00:00:00Z","timestamp":1677801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T00:00:00Z","timestamp":1677801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Shanghai Experimental Animal Research Project of Science and Technology Innovation Action Plan","award":["201409006700"],"award-info":[{"award-number":["201409006700"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To determine the predictive value of quantitative morphological parameters for pigment epithelial detachment (PED) of neovascular age-related macular degeneration (nAMD) patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>One eye from each of 159 patients with nAMD were studied. Polypoidal choroidal vasculopathy (PCV) group included 77 eyes, and non-PCV group 82. Patients received conbercept 0.05\u00a0ml (0.5\u00a0mg) in a 3\u2009+\u2009ProReNata (PRN) treatment regimen. Correlations between retinal morphologic parameters at baseline and best-corrected visual acuity (BCVA) gain at 3 or 12\u00a0months after treatment (structure\u2013function correlations) were assessed. Optical coherence tomography (OCT) scans were used to assess retinal morphologic features including intraretinal cystoid fluid (IRC), subretinal fluid (SRF), PED or PED type (PEDT), and vitreomacular adhesion (VMA). Greatest height (PEDH) and width of PED (PEDW), and volume of PED (PEDV) at baseline were also measured.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      For non-PCV group, BCVA gain from 3 or 12\u00a0months after treatment was\u00a0negatively correlated with PEDV at baseline (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u2009-0.329, -0.312,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.027, 0.037). BCVA gain at 12\u00a0months after treatment was negatively correlated with PEDW at baseline (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u2009-0.305,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.044). For PCV group, there were no correlations with PEDV, PEDH, PEDW, and PEDT in BCVA gain between baseline and 3 or 12\u00a0months after treatment (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&gt;\u20090.05). SRF, IRC, VMA at baseline did not correlate with short-term and long-term BCVA gain in patients with nAMD (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&gt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>For patients with non-PCV, PEDV at baseline was negatively correlated with short-term and long-term BCVA gain, and PEDW was negatively correlated with long-term BCVA gain. On the contrary, quantitative morphological parameters for PED at baseline had no correlation with BCVA gain in patients with PCV.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12886-023-02797-5","type":"journal-article","created":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T04:03:59Z","timestamp":1677816239000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Predictive value of pigment epithelial detachment markers for visual acuity outcomes in neovascular age-related macular degeneration"],"prefix":"10.1186","volume":"23","author":[{"given":"Yiyang","family":"Shu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuxiang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,3]]},"reference":[{"key":"2797_CR1","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.2147\/DDDT.S295223","volume":"15","author":"RM Hussain","year":"2021","unstructured":"Hussain RM, Shaukat BA, Ciulla LM, Berrocal AM, Sridhar J. Vascular endothelial growth factor antagonists: promising players in the treatment of neovascular age-related macular degeneration. Drug Des Devel Ther. 2021;15:2653\u201365.","journal-title":"Drug Des Devel Ther"},{"key":"2797_CR2","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ajo.2018.08.026","volume":"197","author":"K Liu","year":"2019","unstructured":"Liu K, Song Y, Xu G, Ye J, Wu Z, Liu X, Dong X, Zhang M, Xing Y, Zhu S, et al. Conbercept for treatment of neovascular age-related macular degeneration: results of the randomized phase 3 PHOENIX study. Am J Ophthalmol. 2019;197:156\u201367.","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"2797_CR3","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1097\/IAE.0000000000000875","volume":"36","author":"J Qu","year":"2016","unstructured":"Qu J, Cheng Y, Li X, Yu L, Ke X. Efficacy of intravitreal injection of conbercept in polypoidal choroidal vasculopathy: subgroup analysis of the aurora study. Retina. 2016;36(5):926\u201337.","journal-title":"Retina"},{"issue":"5","key":"2797_CR4","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1097\/IAE.0000000000002035","volume":"39","author":"Z Huang","year":"2019","unstructured":"Huang Z, Ding Q, Yan M, Lian H, Chen Z, Chen X, Song Y. Short-tem efficacy of conbercept and ranibizumab for polypoidal choroidal vasculopathy. Retina. 2019;39(5):889\u201395.","journal-title":"Retina"},{"issue":"1","key":"2797_CR5","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1442-9071.2009.02015.x","volume":"37","author":"LM Sakata","year":"2009","unstructured":"Sakata LM, Deleon-Ortega J, Sakata V, Girkin CA. Optical coherence tomography of the retina and optic nerve - a review. Clin Exp Ophthalmol. 2009;37(1):90\u20139.","journal-title":"Clin Exp Ophthalmol"},{"issue":"3","key":"2797_CR6","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/IAE.0b013e31827d2657","volume":"33","author":"FM Penha","year":"2013","unstructured":"Penha FM, Gregori G, Garcia Filho CA, Yehoshua Z, Feuer WJ, Rosenfeld PJ. Quantitative changes in retinal pigment epithelial detachments as a predictor for retreatment with anti-VEGF therapy. Retina. 2013;33(3):459\u201366.","journal-title":"Retina"},{"issue":"4","key":"2797_CR7","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.ophtha.2014.11.017","volume":"122","author":"U Schmidt-Erfurth","year":"2015","unstructured":"Schmidt-Erfurth U, Waldstein SM, Deak GG, Kundi M, Simader C, Group AS. Pigment epithelial detachment followed by retinal cystoid degeneration leads to vision loss in treatment of neovascular age-related macular degeneration. Ophthalmology. 2015;122(4):822\u201332.","journal-title":"Ophthalmology"},{"issue":"7","key":"2797_CR8","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.ophtha.2016.03.037","volume":"123","author":"SM Waldstein","year":"2016","unstructured":"Waldstein SM, Simader C, Staurenghi G, Chong NV, Mitchell P, Jaffe GJ, Lu C, Katz TA, Schmidt-Erfurth U. Morphology and visual acuity in aflibercept and ranibizumab therapy for neovascular age-related macular degeneration in the VIEW trials. Ophthalmology. 2016;123(7):1521\u20139.","journal-title":"Ophthalmology"},{"issue":"1","key":"2797_CR9","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ophtha.2015.09.013","volume":"123","author":"SM Waldstein","year":"2016","unstructured":"Waldstein SM, Wright J, Warburton J, Margaron P, Simader C, Schmidt-Erfurth U. Predictive value of retinal morphology for visual acuity outcomes of different ranibizumab treatment regimens for neovascular AMD. Ophthalmology. 2016;123(1):60\u20139.","journal-title":"Ophthalmology"},{"issue":"8","key":"2797_CR10","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s00417-014-2789-x","volume":"253","author":"L Jang","year":"2015","unstructured":"Jang L, Gianniou C, Ambresin A, Mantel I. Refractory subretinal fluid in patients with neovascular age-related macular degeneration treated with intravitreal ranibizumab: visual acuity outcome. Graefes Arch Clin Exp Ophthalmol. 2015;253(8):1211\u20136.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"2797_CR11","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ajo.2014.04.004","volume":"158","author":"BJ Kim","year":"2014","unstructured":"Kim BJ, Ying GS, Huang J, Levy NE, Maguire MG, Group CR. Sporadic visual acuity loss in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT). Am J Ophthalmol. 2014;158(1):128\u201335 e110.","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"2797_CR12","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1001\/jamaophthalmol.2014.1019","volume":"132","author":"GS Ying","year":"2014","unstructured":"Ying GS, Kim BJ, Maguire MG, Huang J, Daniel E, Jaffe GJ, Grunwald JE, Blinder KJ, Flaxel CJ, Rahhal F, et al. Sustained visual acuity loss in the comparison of age-related macular degeneration treatments trials. JAMA Ophthalmol. 2014;132(8):915\u201321.","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"2797_CR13","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.ophtha.2015.02.031","volume":"122","author":"TA Ciulla","year":"2015","unstructured":"Ciulla TA, Ying GS, Maguire MG, Martin DF, Jaffe GJ, Grunwald JE, Daniel E, Toth CA. Comparison of age-related macular degeneration treatments trials research G: influence of the vitreomacular interface on treatment outcomes in the comparison of age-related macular degeneration treatments trials. Ophthalmology. 2015;122(6):1203\u201311.","journal-title":"Ophthalmology"},{"issue":"9","key":"2797_CR14","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1097\/IAE.0b013e3182993f66","volume":"33","author":"S Mrejen","year":"2013","unstructured":"Mrejen S, Sarraf D, Mukkamala SK, Freund KB. Multimodal imaging of pigment epithelial detachment: a guide to evaluation. Retina. 2013;33(9):1735\u201362.","journal-title":"Retina"},{"issue":"1","key":"2797_CR15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jfo.2018.04.017","volume":"42","author":"M Sastre-Ibanez","year":"2019","unstructured":"Sastre-Ibanez M, Martinez-Rubio C, Molina-Pallete R, Martinez-Lopez-Corell P, Wu L, Arevalo JF, Gallego-Pinazo R. Retinal pigment epithelial tears. J Fr Ophtalmol. 2019;42(1):63\u201372.","journal-title":"J Fr Ophtalmol"},{"issue":"9","key":"2797_CR16","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1097\/IAE.0b013e3181e7976b","volume":"30","author":"KB Freund","year":"2010","unstructured":"Freund KB, Zweifel SA, Engelbert M. Do we need a new classification for choroidal neovascularization in age-related macular degeneration? Retina. 2010;30(9):1333\u201349.","journal-title":"Retina"},{"issue":"5","key":"2797_CR17","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.ophtha.2019.11.004","volume":"127","author":"RF Spaide","year":"2020","unstructured":"Spaide RF, Jaffe GJ, Sarraf D, Freund KB, Sadda SR, Staurenghi G, Waheed NK, Chakravarthy U, Rosenfeld PJ, Holz FG, et al. Consensus nomenclature for reporting neovascular age-related macular degeneration data: consensus on neovascular age-related macular degeneration nomenclature study group. Ophthalmology. 2020;127(5):616\u201336.","journal-title":"Ophthalmology"},{"issue":"3","key":"2797_CR18","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.survophthal.2007.02.008","volume":"52","author":"S Zayit-Soudry","year":"2007","unstructured":"Zayit-Soudry S, Moroz I, Loewenstein A. Retinal pigment epithelial detachment. Surv Ophthalmol. 2007;52(3):227\u201343.","journal-title":"Surv Ophthalmol"},{"issue":"5","key":"2797_CR19","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1097\/IAE.0b013e3182755793","volume":"33","author":"M Inoue","year":"2013","unstructured":"Inoue M, Arakawa A, Yamane S, Kadonosono K. Variable response of vascularized pigment epithelial detachments to ranibizumab based on lesion subtypes, including polypoidal choroidal vasculopathy. Retina. 2013;33(5):990\u20137.","journal-title":"Retina"},{"issue":"5","key":"2797_CR20","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/s10384-018-0605-6","volume":"62","author":"M Ogasawara","year":"2018","unstructured":"Ogasawara M, Koizumi H, Yamamoto A, Itagaki K, Saito M, Maruko I, Okada AA, Iida T, Sekiryu T. Prognostic factors after aflibercept therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy. Jpn J Ophthalmol. 2018;62(5):584\u201391.","journal-title":"Jpn J Ophthalmol"},{"issue":"4","key":"2797_CR21","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jfo.2013.08.006","volume":"37","author":"A Ozkaya","year":"2014","unstructured":"Ozkaya A, Alkin Z, Osmanbasoglu OA, Ozkaya HM, Demirok A. Intravitreal ranibizumab for neovascular age-related macular degeneration patients with good baseline visual acuity and the predictive factors for visual outcomes. J Fr Ophtalmol. 2014;37(4):280\u20137.","journal-title":"J Fr Ophtalmol"},{"issue":"1","key":"2797_CR22","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s41598-018-36704-6","volume":"9","author":"TT Lai","year":"2019","unstructured":"Lai TT, Hsieh YT, Yang CM, Ho TC, Yang CH. Biomarkers of optical coherence tomography in evaluating the treatment outcomes of neovascular age-related macular degeneration: a real-world study. Sci Rep. 2019;9(1):529.","journal-title":"Sci Rep"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-023-02797-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-023-02797-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-023-02797-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T04:04:37Z","timestamp":1677816277000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-023-02797-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,3]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2797"],"URL":"https:\/\/doi.org\/10.1186\/s12886-023-02797-5","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,3]]},"assertion":[{"value":"19 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all the patients. This study protocol was reviewed and approved by Shanghai General Hospital. In the following study, all methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"83"}}